1700001G01Rik activators consist of a diverse array of chemical compounds, each participating in unique signaling pathways to augment the function of 1700001G01Rik. For instance, Forskolin, by increasing intracellular cAMP levels, might indirectly enhance 1700001G01Rik activity through cAMP-dependent protein kinases that phosphorylate proteins in proximity to or in direct interaction with 1700001G01Rik. Similarly, PMA engages protein kinase C, which may phosphorylate partners of 1700001G01Rik, leading to an enhancement of its activity. The calcium ionophores Ionomycin and A23187 raise intracellularcalcium levels, which in turn could activate calcium-dependent kinases that affect 1700001G01Rik function either by direct phosphorylation or through phosphorylation of associated proteins. Epigallocatechin gallate (EGCG) serves as a kinase inhibitor that may relieve inhibitory phosphorylation controls on 1700001G01Rik, thereby potentiating its activity. Additionally, Sphingosine-1-phosphate potentially activates pathways involving kinases that could phosphorylate and thereby activate 1700001G01Rik or its interacting partners.
In parallel, the PI3K inhibitors LY294002 and Wortmannin could indirectly enhance 1700001G01Rik activity by shifting cellular signaling towards pathways that activate 1700001G01Rik when PI3K is inhibited. U0126 and SB203580, by inhibiting MEK1/2 and p38 MAPK respectively, might also cause a signaling reroute that favors 1700001G01Rik activation. Thapsigargin further contributes to this network by disrupting calcium homeostasis, thus stimulating calcium-dependent signaling which might intersect with pathways influencing 1700001G01Rik activity. Lastly, Genistein, through tyrosine kinase inhibition, could reduce competitive phosphorylation, thereby freeing pathways to enhance 1700001G01Rik's activity. Collectively, these compounds influence distinct but interconnected signaling pathways that converge to enhance the functional activity of 1700001G01Rik, demonstrating the complexity and interconnectedness of intracellular signaling and its impact on specific protein functions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC). PKC activation can lead to phosphorylation of substrates that may include proteins interacting with or regulating 1700001G01Rik, thereby enhancing its activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Ionomycin functions as a calcium ionophore, raising intracellular calcium levels. Elevated calcium may activate calcium-dependent kinases, which can modulate the function of 1700001G01Rik by altering its phosphorylation state or interaction with binding partners. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
EGCG is a kinase inhibitor that could inhibit kinases that normally phosphorylate inhibitors of 1700001G01Rik. This could lead to a reduction in inhibitory control and thus enhance the activity of 1700001G01Rik. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $162.00 $316.00 $559.00 $889.00 $1693.00 | 7 | |
Sphingosine-1-phosphate activates sphingosine-1-phosphate receptors, which may lead to downstream signaling cascades involving kinases that phosphorylate and activate proteins that interact with 1700001G01Rik, enhancing its activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is a PI3K inhibitor. By inhibiting PI3K, it can lead to a compensatory response that enhances the activity of alternative signaling pathways, potentially including those that activate 1700001G01Rik. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580 is a p38 MAPK inhibitor. Inhibition of p38 MAPK could shift signaling dynamics in the cell, leading to the activation of compensatory pathways that enhance the activity of 1700001G01Rik. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
A23187 acts as a calcium ionophore, similar to ionomycin, and enhances intracellular calcium, which can activate calcium-dependent signaling pathways potentially linked to the activation of 1700001G01Rik. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to increased cytosolic calcium levels which may activate signaling pathways that enhance 1700001G01Rik activity through calcium-dependent phosphorylation. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Genistein acts as a tyrosine kinase inhibitor, which may reduce competitive phosphorylation events and thereby enhance signaling pathways that activate 1700001G01Rik. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin is another PI3K inhibitor that, like LY294002, may enhance the activity of 1700001G01Rik through the activation of compensatory signaling pathways when PI3K is inhibited. | ||||||